IR contact details Carla Bretes Director Investor Relations and Business Development e: ir@moonlaketx.com Upcoming events Nov 1 - Nov 3 2024 SHSA (Symposium on HS Advances) Nov 14 - Nov 19 2024 ACR Nov 19 - Nov 21 2024 Jefferies London Healthcare Conference View All Events View All Events + Corporate presentations Corporate presentation View All Presentations View All Presentations + Latest press releases Sep 09 2024 MoonLake Immunotherapeutics to host a Capital Markets Update on Wednesday, September 11 Aug 07 2024 MoonLake Immunotherapeutics Reports Second Quarter 2024 Financial Results and Announces a Capital Markets Update for September 11 Jun 10 2024 MoonLake Immunotherapeutics Announces Positive Regulatory Feedback from both FDA and EMA on Path for the Phase 3 Program for the Nanobody® sonelokimab in Psoriatic Arthritis View All News View All Press Releases +
Aug 07 2024 MoonLake Immunotherapeutics Reports Second Quarter 2024 Financial Results and Announces a Capital Markets Update for September 11
Jun 10 2024 MoonLake Immunotherapeutics Announces Positive Regulatory Feedback from both FDA and EMA on Path for the Phase 3 Program for the Nanobody® sonelokimab in Psoriatic Arthritis